Researchers at the University of Arizona College of Medicine – Tucson have received a $1.9 million grant from the National Institutes of Health to investigate the use of copper as a next-generation antibiotic.
Copper has been recognised for thousands of years for its antimicrobial properties, but there is still room for a deeper understanding of its mechanisms of action.
If successful, copper could be used as a potential agent against harmful microorganisms and help address the global health crisis of antibiotic resistance.
Copper has been used by various civilisations to mitigate the risks of bacterial infections, due to its effectiveness at preventing bacterial growth. However, there is still significant untapped potential.
Antibiotic resistance poses a serious threat. Certain strains of bacteria are mutating to escape the effects of established antimicrobial treatments.
Copper has the unique ability to disrupt critical biological processes in bacteria and can be particularly effective in pathogens such as Streptococcus pneumoniae.
The laboratory’s approach is centred around overwhelming bacteria with copper, potentially tricking them into synthesising essential proteins using inappropriate metals.
Johnson’s previous research has begun to uncover the mechanisms behind copper-induced bacterial toxicity, and his current project aims to clarify how copper’s interaction with other bacterial pathogens may inform treatment options.
This innovative research could offer fresh perspectives on preventing and managing lethal infections and potentially lead to novel therapeutic strategies.
Scholars and health professionals are watching closely as this research develops, hoping that Johnson’s work might lead to a revolutionary breakthrough in our battle against antibiotic-resistant bacteria.